HONG KONG, Aug. 21, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that its investigational next-generation B7-H3-targeting antibody-drug conjugate (ADC), AK157D1, has received clinical trial clearance from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA). The clearance allows initiation of...
CHANGZHOU, China, Aug. 5, 2026 /PRNewswire/ -- JIN MEDICAL INTERNATIONAL LTD. (Nasdaq: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the...
BEIJING, Aug. 5, 2026 /PRNewswire/ -- Elong Power Holding Limited (Nasdaq: ELPW) ("Elong Power" or the "Company"), a comprehensive provider dedicated to the R&D,...
ABU DHABI, UAE, Aug. 5, 2026 /PRNewswire/ -- Agthia Group PJSC (AGTHIA: UH), one of the region's leading food and beverage companies, today reported its first-half and...
ABU DHABI, UAE, Aug. 5, 2026 /PRNewswire/ -- Agthia Group PJSC (AGTHIA: UH), one of the region's leading food and beverage companies, today reported its first-half and...
Veteran executive to drive international expansion and build on company momentum in the U.S. residential energy storage market SAN JOSE, Calif., Aug. 5,...